Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 4
Submit an article Journal homepage
187
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series

Chia-Yu Chiua Department of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, TX, USA;b Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-5241-3435View further author information
ORCID Icon,
Khalis Mustafayevb Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Hans C. Leec Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Elisabet E. Manasanchc Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Eduardo Yepez Guevarab Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Harrys A. Torresb Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;d Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0814-604XView further author information
ORCID Icon
Pages 900-903 | Received 12 Dec 2022, Accepted 18 Feb 2023, Published online: 08 Mar 2023

References

  • US Food and Drug Administration. FDA approves isatuximab-IRFC for multiple myeloma [cited 2022 Nov 8]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-isatuximab-irfc-multiple-myeloma-0.
  • Raedler LA. Darzalex (daratumumab): first anti-CD38 monoclonal antibody approved for patients with relapsed multiple myeloma. Am Health Drug Benefits. 2016;9(Spec Feature):70–73.
  • Lee SK, Sung PS, Park SS, et al. Reactivation of resolved hepatitis B after daratumumab for multiple myeloma. Clin Infect Dis. 2021;73(6):e1372-5–e1375.
  • Chiu, CY., Patel, K., Thomas, S.K. et al. Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int (2022). https://doi.org/10.1007/s12072-022-10462-0
  • Seeff LB. Sustained virologic response: is this equivalent to cure of chronic hepatitis C? Hepatology. 2013;57(2):438–440.
  • Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology. 2009;49(2):665–675.
  • Hosry J, Angelidakis G, Kaseb A, et al. Inhibition of hepatitis C virus replication induced by chemotherapy: a prospective observational study. Clin Infect Dis. 2018;67(10):1635–1636.
  • Mahale P, Kontoyiannis DP, Chemaly RF, et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012;57(6):1177–1185.
  • Torres HA, Hosry J, Mahale P, et al. Hepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational study. Hepatology. 2018;67(1):36–47.
  • Abdallah N, Murray D, Dispenzieri A, et al. Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab. Leukemia. 2022;36(5):1426–1428.
  • Yamazaki T, Joshita S, Ichijo T, et al. Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: case report and review of the literature. J Infect Chemother. 2021;27(12):1750–1755.
  • Simmons B, Saleem J, Hill A, et al. Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(6):683–694.
  • Mahale P, Okhuysen PC, Torres HA. Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals? Clin Gastroenterol Hepatol. 2014;12(6):1051–1054.e1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.